Increased resource utilization is one goal of new architectures. At Livermore Computing, these include AI accelerators such as Samba Nova and Cerebras systems and El Capitan's Rabbits.
Topic: CogSim/AI/ML Hardware
In a milestone for supercomputing-aided drug design, LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer.
LLNL’s fusion ignition breakthrough, more than 60 years in the making, was enabled by a combination of traditional fusion target design methods, HPC, and AI techniques.
Can novel mathematical algorithms help scientific simulations leverage hardware designed for machine learning? A team from LLNL’s Center for Applied Scientific Computing aimed to find out.
As CTO of Livermore Computing, de Supinski is responsible for formulating, overseeing, and implementing LLNL’s large-scale computing strategy, requiring managing multiple collaborations with the HPC industry and academia.
